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Abstract
Molecular and intra-cellular mechanisms involved in the regulation of apoptosis processes in
endometrial cells are poorly understood and documented. We have investigated the possibility that
Akt survival pathway might be involved in the regulation of apoptosis in the uterus during the
estrous cycle. Rats with regular estrous cycle (4 days) were killed at different days of estrous cycle
(diestrus, proestrus, estrus and metestrus). Uteri were collected and fixed for
immunohistochemical staining (IHC) and apoptotic cell death detection by [TdT]-mediated
deoxyuridinetriphosphate nick end-labelling (TUNEL) or endometrial protein extracts collected
for Western analysis. TUNEL analysis revealed that apoptosis was mainly found at estrus compared
to other day of estrous cycle. TUNEL positive cells were apparent in luminal epithelial cells only.
No apoptotic cells were observed at proestrus. In contrast, proliferation was maximal at proestrus
as confirmed with the expression of CDC47/MCM7 (a cell proliferation marker). Intact form of
caspase-3 was maximal at proestrus and was reduced only at estrus. Likewise, presence of a specific
cleaved caspase-3 fragment was observed only at estrus and IHC revealed that cleaved caspase-3
signal was found in luminal epithelial cells. PTEN protein, a phosphatase involved in the regulation
of Akt phosphorylation, was present at all days of estrous cycle and showed no significant
regulation in relation to cycle. Expression of phospho-Akt (the activated form of Akt) was present
at metestrus, diestrus, and proestrus but decreased significantly at estrus. Akt protein expression
was maximal at estrus. IHC revealed that Akt expression was high in both stromal and epithelial
cells at estrus. Further studies using ovariectomized rats demonstrated that 17β-estradiol
increased endometrial cell proliferation which was accompanied by an increase of both Akt
expression and phosphorylation. These results suggest that increased Akt expression and activity
in response to estradiol may be an important mechanism to protect endometrial cells from
apoptotic triggering and to induce endometrial cell proliferation, whereas inhibition of Akt activity
leads to caspase-3 activation and apoptosis in endometrial cells.
Introduction
Apoptosis is a mechanism by which uterine luminal epi-
thelium and glands degenerate in the absence of embry-
onic factors and regenerate in a cycling fashion through
the estrous cycle. Sex steroids (estrogen and progesterone)
are directly responsible for the histological and morphog-
ical changes in the uterus during estrous cycle. Studies
have shown highest apoptosis expression in lining
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epithelium at estrus in mouse [1] and rat .[2,3]. Other
studies have shown that estrogen induces uterine epithe-
lial cell proliferation and estrogen withdrawal results in
cell death [4–6]. However, little is known about the cellu-
lar and molecular mechanisms involved in the regulation
of apoptosis in the uterus. Since menses are absent in
rodents as compared to humans and primates, there must
be important mechanisms controlling the balance
between survival and death factors in order to maintain
integrity of endometrium throughout the estrous cycle,
particularly following estrogen-induced proliferation and
absence of embryonic signal.
Akt, a serine/threonine protein kinase also known as PKB,
is activated by phosphorylation at threonine 308 and ser-
ine 473 in response to growth factors or cytokines .[7–9]
through phosphatidylinositol 3-kinase (PI 3-K). Once
phosphorylated Akt has been shown to 1) phosphorylate
and block the action of several pro-apoptotic proteins
such as Bad [8], and 2) block cytochrome C release from
the mitochondria through the regulation of Bcl-2 [10].
This is supported by the observation that an activated
form of Akt is able to block apoptosis [11]. PTEN (phos-
phatase and tensin homolog deleted in chromosome 10)
gene encodes a 403-amino acid polypeptide with lipid
phosphatase activity. The PTEN protein dephosphorylates
position D3 of phosphatidylinositol 3,4,5-triphosphate
(PIP3) and generates inactive PIP2 [12]. PIP3 is a direct
product of PI 3-K and regulates PDK1, a kinase that phos-
phorylates and activates Akt. Thus, PTEN is a key negative
regulator of Akt activity [13]. Studies using MCF-7 cells
showed that 17β-estradiol effects are mediated through PI
3-K pathway and induced Akt phosphorylation [14,15]
indicating that this survival pathway is important for
estrogen signaling.
Caspases are well known and documented proteases
involved in the activation of apoptosis. Once activated
from their proactive forms, caspases target important pro-
teins involved in cell proliferation and survival (for a
review see [16]). Caspase-3 is one of the key executioner
of apoptosis. During the execution phase of apoptosis,
caspase-3 is responsible or in part for the proteolysis of a
large number of substrates, each of which contains a com-
mon Asp-Xaa-Xaa-Asp (DXXD) motif originally described
by Lazebnik et al. [17]. We have recently shown that Akt is
also a new target for caspase-3 cleavage, indicating that
Akt survival pathway inhibition is an important mecha-
nism for apoptosis activation [18].
Although the regulation and importance of Akt has been
described in other systems, the presence and role of Akt
has not been documented in the cycling uterus. Recent
studies revealed that Akt phosphorylation on serine 473
as well as its nuclear translocation are stimulated by prol-
actin in decidual cells and act through PI-3K pathway to
exert antiapoptotic effect in rat deciduas [19]. It is sug-
gested that Akt may also be an important and regulated
survival factor in endometrium during the rat estrous
cycle. In the present study, regulation of apoptosis was
measured in rat uterus during the four stages of estrous
cycle (proestrus, estrus, metestrus and diestrus). Regula-
tion of Akt survival pathway and caspase-3 activation were
investigated using immunohistochemistry (IHC) and
Western analysis using phospho-specific and specific-
cleaved-caspase-3 antibodies to determine their involve-
ment in the regulation of apoptotic processes.
Materials and Methods
Reagents
PhosphoPlus Akt (Ser473), PhosphoPlus Akt (Ser473)
IHC specific, Akt, PTEN, procaspase-3 and cleaved specific
caspase-3 antibodies were obtained from New England
Biolabs (Mississauga, ON). CDC47/MCM7 antibody was
obtained from Medicorp (Montréal, QC). β-actin anti-
body was purchased through Cedarlane (Milton, ON).
Vectastain ABC Kit for rabbit IgG was purchased from Vec-
tor Laboratories Inc. (Burlingame, CA). In Situ  Cell Death
detection, Protease Inhibitor Cocktail Tablets, POD and
DAB substrate were purchases from Roche (Laval, QC).
17β-Estradiol (E2) was purchased from Laboratoire Mat
(Québec, QC).
Animals
Mature Sprague-Dawley female rats (200–225 g) were
obtained from Charles River Laboratories Canada. Ani-
mals were maintained on standard chow and water,
which were available ad libitum , in animal facilities illu-
minated on a normal 12 hour cycle. All procedures were
performed in accordance with guidelines of the Canadian
Council on Animal Care for the handling and training of
laboratory animals and the Good Health and Animal Care
Committee of the Université du Québec à Trois-Rivières.
Stages of the estrous cycle were confirmed by vaginal
smears. Rats with three regular cycles of 4 days were used
in these experiments and killed at various stages of the
estrous cycle (diestrus, proestrus, estrus and metestrus).
Uteri were collected and fixed for immunohistochemical
staining (IHC) and apoptotic cell death detection by
[TdT]-mediated deoxyuridinetriphosphate nick end-label-
ling (TUNEL) or endometrial protein extracts collected by
scraping the endometrium for Western analysis. To deter-
mine the effect of estrogen, rats were ovariectomized for at
least 10 days and then injected with E2. Animals were
treated for a total of 3 days and killed after hormone treat-
ment according to previous preliminary time-course stud-
ies done in our laboratory (unpublished information). E2
was dissolved with sesame oil, and administered by sub-
cutaneous injection. Sesame oil was injected into control
animals. The dose administered was 40 µg/kg/day (E2).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/47
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Immunohistochemistry
The uterus was fixed in 4% paraformaldehyde solution
and embedded in paraffin. Tissue sections 7 µm thick
were mounted on polylysine-coated slides, deparaffin-
ized, rehydrated, and then heated with 10 mM citrate
buffer (pH 6). After two wash with PBS, slides were then
incubated with 0.3 % hydrogen peroxide in methanol for
30 min to quench endogenous peroxidase activity. After
washing with PBS, tissues were incubated with blocking
serum (Vectastain ABC Kit) at room temperature for 1 h.
Then, a primary antibody (Akt 1:100; CDC47/MCM7
1:200; Phospho-Akt IHC 1:50; PTEN 1:100 and cleaved
caspase-3 1:50) was added to the slides and incubated at
4° C overnight. After washing 5 min in PBS, tissue sec-
tions were incubated for 30 min with 3 µg/ml biotinylated
antibody (anti-rabbit or anti-mouse). Subsequently,
slides were washed with PBS and incubated with avidin-
biotin complex reagent containing horseradish peroxi-
dase for 30 min. Again washed with PBS for 5 min and
color development was achieved using DAB substrate. The
tissue sections were counterstained with haematoxylin.
Negative controls were performed using the same proto-
col without primary antibody.
Terminal deoxynucleotidyl transferase-mediated nick end-
labeling (TUNEL)
Tissue sections were deparaffinized, rehydrated and rinsed
with PBS. They were incubated with proteinase K (20 µg/
ml) for 30 min at room temperature. Slides were washed
two times with PBS, the endogenous peroxidase was inac-
tivated with 0.3 % hydrogen peroxide in methanol for 30
min. Slides were rinsed and incubated with 10 mM citrate
solution, two min on ice. Then, tissue sections were rinsed
with PBS and incubated with TdT labelling reaction (In
Situ Cell Death Detection, POD) for 30 min at 37°C in
humidified environment. Slides were washed three times
in PBS and tissue sections were blocked with 3% BSA for
20 min at room temperature. Converter-POD solution
was added to the slides and incubated 30 min at 37°C in
humidified environment. Slides were washed 5 min in
PBS, colour development was achieved using DAB sub-
strate and counterstained with haematoxylin. Negative
control was performed using the same protocol without
TdT enzyme.
Protein extraction and Western analysis
Endometrium from each uterus was scraped using a glass
microscope slide and homogenized using a pipette in the
lysis buffer (PBS 1X pH 7.4; 1% Nonidet P-40; 0.5%
Sodium deoxycholate; 0.1% SDS; Protease Inhibitor
Cocktail Tablets (Roche)). Homogenates were centrifuged
(12,000 × g for 20 min at 4°C) to remove insoluble mate-
rial. The supernatant was recovered and stored at -20°C
pending analysis. Protein content was determined with
the Bio-Rad DC Protein Assay. Concentrations of reagents
found in the lysis buffer were chosen to avoid any interfer-
ence with the protein assay. Protein extracts (50 µg) were
heated at 94°C for 3 min, resolved by 10% SDS-PAGE and
electrotransferred to nitrocellulose membranes using a
semidry transfer (Bio-Rad, Mississauga, ON). The mem-
branes were then blocked 2 h at room temperature with
PBS containing 5 % milk powder, then incubated with Akt
1:1000 ; Procaspase-3 1:1000; CDC47/MCM7 1:1000;
Phospho-Akt 1:250; PTEN 1:500 and cleaved caspases
1:1000 and subsequently with horseradish peroxidase-
conjugated anti-rabbit or anti-mouse secondary antibody
(1:3000; room temperature for 45 min). All membranes
were reprobed with a antibody specific to β-actin which
was used as an internal standard. Densitometrical analy-
ses were performed on both films (protein of interest and
β-actin) using the GelDoc 2000 and the Quantity One
software (Bio-Rad, Mississauga, ON). Results are
expressed as a ratio protein of interest/β-actin to correct
for loading for each endometrial sample.
Statistical analysis
Western analyses of cycling animals were repeated six to
eight times (6 to 8 different rats/endometrial extract per
day of estrous cycle). Endometrial extracts from each rats
was assessed individually. Western analyses of ovariect-
omized rats treated with E2 were repeated 5 times (5 dif-
ferent rats/ endometrial extracts per group including
control). Endometrial extracts from each rats was assessed
individually for both studies. Results subjected to statisti-
cal analyses were expressed as means ± SEM. Data were
subjected to one-way ANOVA (PRISM software version
4.0; GraphPad, San Diego, CA). Differences between
experimental groups were determined by the Tukey's test.
Results
Apoptosis and proliferation analyses through the estrous 
cycle
To confirm proliferation and cell death status of endome-
trial cells in our current model, uteri of cycling rats were
recovered to perform TUNEL, IHC and Western analyses.
Estrous cycle determination was carried out using vaginal
smear and animals were classified according to the type of
cell present in the smear. TUNEL analysis showed that
apoptosis was maximal at estrus, present at metestrus and
weakly detectable at diestrus and proestrus (Fig. 1, 2 and
3). Apoptosis was mainly located in the luminal epithelial
cells at estrus. These results were in accordance with
results obtained previously [3]. On the other hand, cell
proliferation was maximal at proestrus as determined by
the expression of CDC47/MCM7 (cell proliferation
marker) and was significantly reduced at estrus. Intact
form of caspase-3 (Procaspase-3) was maximal at proe-
strus, metestrus and diestrus but was reduced only at
estrus (Fig. 1 and 3). Caspase-3 was active mainly at
estrus, as demonstrated by the presence of a specificReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/47
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cleaved fragment using Western and IHC analyses. As
shown by IHC, Western analysis revealed that CDC47/
MCM7 was reduced at estrus compared to other days of
the estrous cycle.
Regulation of Akt and PTEN expression and activity during 
the estrous cycle
In order to determine the possibility that Akt and PTEN
might be regulated by sex steroids during estrous cycle,
Figure 1
Proliferation and apoptosis in the rat endometrium during the estrous cycle as demonstrated by Western analyses. Rats were 
killed at different days of estrous cycle (diestrus, proestrus, estrus and metestrus) and total endometrial proteins were col-
lected. A) Proliferation as determined by Western analysis of CDC47/MCM7. B) Apoptosis as determined by Western analysis 
of intact and cleaved caspase-3. Data represent the mean ± SEM of six independent experiments for CDC47/MCM7 and five 
for intact and cleaved caspase-3. β-actin blots shown were used as controls to correct for loading in each lane. Blots shown are 
from one representative experiment. Graphics represent Western blots densitometrical analysis. Columns with different 
superscript are significantly different (different letters are different from each other) (p < 0.05).
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Figure 2
Proliferation and apoptosis in the rat endometrium during the estrous cycle as demonstrated by TUNEL and IHC. Rats were 
killed at different days of estrous cycle (diestrus, proestrus, estrus and metestrus). Uteri were collected, fixed and sectioned 
for detection of apoptotic cells by TUNEL and IHC of CDC47/MCM7 and cleaved caspase-3. IHC and TUNEL shown are from 
one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per day of 
estrous cycle. Arrows indicate example of apoptotic cells. L = lumen, LE = luminal epithelium, S = stroma.
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Figure 3
Apoptotic and proliferative endometrial cell count during the estrous cycle. TUNEL and IHC of CDC47/MCM7 were used to 
count positive apoptotic and proliferative luminal epithelial cells as shown in figure 2. A minimum of 200 luminal epithelial cells 
per day of estrous cycle were counted in each experiment and results are presented as the percentage of proliferative positive-
cells (A), % of TUNEL apoptotic-positive cells (B), and % of cleaved caspase-3 positive cells (C). Data represent the mean ± 
SEM of six different rat endometrial sections per day of estrous cycle. Columns with different superscript are significantly dif-
ferent (different letters are different from each other) (p < 0.05). *Significantly different (p < 0.05).
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Akt and PTEN protein abundance were measured by West-
ern analyses and localized by IHC. PTEN protein was
present at all days of estrous cycle and the estrous cycle did
not influence expression of this protein significantly (Fig.
4 and 5). However, expression of total Akt protein was
increased from proestrus to estrus. Akt and PTEN proteins
were mainly localized in the luminal and glandular epi-
thelium as demonstrated by IHC (Fig. 5). Phospho-Akt
Figure 4
Expression of Akt, Phospho-Akt and PTEN during the estrous cycle. Endometrial proteins were extracted from uteri at differ-
ent days of estrous cycle for Western analysis: A) Akt, B) Phospho-Akt and C) PTEN. β-actin blots shown were used as con-
trols to correct for loading in each lane. Graphics represent Western blots densitometrical analysis: Akt (mean ± SEM of seven 
independent experiments), Phospho-Akt (mean ± SEM of six independent experiments) and PTEN (mean ± SEM of eight inde-
pendent experiments). Blots shown are from one representative experiment. Columns with different superscript are signifi-
cantly different (different letters are different from each other) (p < 0.05).
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(the activated form of Akt) was present at metestrus, die-
strus and proestrus but was significantly reduced 3.1 fold
at estrus (Fig. 4). IHC revealed that phospho-Akt was pri-
marily located in the luminal and glandular epithelial
cells (Fig. 5). Interestingly, as shown by Western analysis,
IHC confirmed that phospho-Akt expression was lower at
estrus and that phospho-Akt was predominantly localized
at the membrane level facing the uterine lumen. In other
days of estrous cycle (metestrus, diestrus and proestrus),
phospho-Akt signal was found mainly in the cytoplasm
and nucleus. These results clearly demonstrate a redistri-
bution of Akt protein from the cytoplasm to cell mem-
brane only at estrus.
Influence of 17β-estradiol in the regulation of Akt expres-
sion and phosphorylation
To further determine if 17β-estradiol might be involved in
the regulation Akt phosphorylation/activity and expres-
sion, ovariectomized rats were treated with 17β-estradiol
for 3 days. The results indicated that 17β-estradiol
increased endometrial cell proliferation significantly (as
determined by the expression of CDC47/MCM7) (Fig. 6).
Furthermore, 17β-estradiol significantly induced both
total Akt protein expression and phosphorylation. IHC
revealed that 17β-estradiol induced both Akt expression
and phosphorylation and was found at the cellular mem-
brane as observed at estrus. IHC studies confirmed in ova-
riectomized rats treated by 17β-estradiol that both Akt
expression and phosphorylation was increased in
endometrial cells (Fig. 7). Increased endometrial cell pro-
liferation (epithelial and stromal) in response to 17β-
estradiol was confirmed using CDC47/ MCM7 prolifera-
tion marker (Fig. 7).
Discussion
This study is the first to show the presence, activity and
regulation of Akt in the non-pregnant rat uterus. This sur-
vival factor is well known in other systems for its inhibi-
tory effect on apoptosis triggering. Apoptosis has been
shown to be present in the rat .[2,3] and mouse [1]
endometrium during the estrous cycle. Apoptotic index
was found to be high at estrus which was accompanied
with a low level of estrogen receptor-α and high level of
progesterone receptor. Since in the endometrium, growth
of epithelial cells is dependent on estrogens and proges-
terone, and removal of ovarian hormones has been
reported to cause cell death in rabbit and hamster [20,21],
sex steroids take part actively in the balance of prolifera-
tion versus cell death in this tissue. Indeed, the appear-
ance of apoptosis in epithelial cells of the endometrium
following ovariectomy or treatment with the antiproges-
tin RU486 has been described in pseudopregnant rabbits
[22] and in primary cell culture [23,24]. However, molec-
ular and cellular mechanisms involved in the regulation
of apoptosis in the uterus are poorly documented in the
literature. We have recently demonstrated in human ovar-
ian cancer cells [18] and rat granulosa cells [25] the
importance of Akt phosphorylation status in relation to
cell survival and chemoresistance. Many other studies
have demonstrated the involvement of Akt on apoptosis
inhibition through the activation of several survival fac-
tors [26]. Since apoptosis has been found in the
endometrium and that a recent study showed activation
of Akt in response to estradiol [27], we hypothesized that
Akt might be an important regulator of uterine function
throughout the rat estrous cycle. Given that menses are
absent in the rodents uterus, there must be precise intra-
cellular systems involved in the regulation of cell death
and cellular cleaning (proliferation versus apoptosis) in
the endometrium after estrogen withdrawal in the
absence of embryonic factors.
As demonstrated previously by others [3], apoptosis was
evident in luminal epithelial cells at estrus and prolifera-
tion was maximal at proestrus. As hypothesized, Akt activ-
ity/phosphorylation was high at proestrus and Akt was
strongly expressed and localized in the lining epithelium
and glands. Indeed, Akt activity/phosphorylation
decreased at estrus whereas cell proliferation was low as
demonstrated by the decrease of CDC47/MCM7 prolifer-
ation marker. Although, Akt phosphorylation was
reduced at estrus, IHC revealed a specific pattern of phos-
pho-Akt expression in luminal epithelial cells and was dis-
tributed mainly at the membrane level facing the uterine
lumen. Translocation at the plasma membrane of phos-
pho-Akt from the nucleus and/or cytoplasm suggests that
its presence at the membrane level may not allow phos-
pho-Akt to be active in term of survival signaling. A recent
study demonstrated that transient membrane association
is required for the physiological activation of Akt indicat-
ing that correct subcellular localization is crucial for the
activation of the kinase, and it may also allow its appro-
priate inactivation by phosphatases [28]. One example of
such phosphatase is phosphatase and tensin homologue
tumor suppressor PTEN [13], a phosphatase found and
active at the plasma membrane .[29]. PTEN directly
dephosphorylates the phospholipid PIP3 which is essen-
tial for Akt phosphorylation [12]. The present results
clearly show that PTEN protein was present in the
endometrium and was not influenced by hormonal
changes observed during the estrous cycle. Indeed, recruit-
ment of Akt at the membrane level may be a mechanism
by which PTEN or unknown phosphatases act on Akt to
inactivate its function.
Since the levels of estrogen are maximal at proestrus and
further decrease at estrus, we have used ovariectomized
rats to determine the possible involvement of 17β-estra-
diol in the regulation of Akt phosphorylation. Akt and
estrogen have been shown to be involved in the regulationReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/47
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Figure 5
IHC of Akt, Phospho-Akt and PTEN in rat endometrium during the estrous cycle. IHC shown are from one representative 
experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per day of estrous cycle. Arrows 
indicates strong redistribution of Akt and Phospho-Akt at the membrane level. LE = luminal epithelium, S = stroma.
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and downstream signaling in different systems such as
EGF, IGF-1 and GH [30,31], endothelial nitric oxide syn-
thase (eNOS) .[32], and FSH [33] regulation pathways.
Recently, using both wild-type (WT) and ER alpha knock-
out (alpha ERKO) mice, it has been shown that ERα is
necessary for IGF-1 induction of uterine nuclear prolifera-
tive responses and that IGF-1 signaling is dependent of
Akt .[34]. Moreover in ERKO mice, lower levels of vascular
nitric oxide has been found suggesting a crucial role of
ERα in the regulation of these processes [35]. A recent
study showed that there was an apparent increase in Akt
activity upon brief stimulation with 17β-E2 in CHO cells
transfected with ERα whereas 17β-E2 had no effect on Akt
activity in cells transfected with control vector or ERβ [36].
The present results clearly showed an increase of Akt phos-
phorylation in response to 17β-estradiol. As shown in
another system [36], it is possible that the activation of
estrogen receptor may activate Akt phosphorylation
through a signaling mechanism not yet identified in the
endometrium. PTEN protein expression was constant
Figure 6
Expression of CDC47/MCM7 (A), Akt (B) and Phospho-Akt (C) in response to 17β-estradiol (E2) in rat endometrium. Animals 
were ovariectomized for at least 10 days and then injected daily with E2 (or vehicle for control group) for 3 days. Rats were 
killed and endometrial proteins were collected for Western analysis. β-actin blots shown were used as controls to correct for 
loading in each lane. Blots shown are from one representative experiment. Graphics represent western blots densitometrical 
analysis and are the mean ± SEM of five independent experiments (5 different rats/endometrial extract per treatment group). 
*Significantly different from control (p < 0.001).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/47
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Figure 7
IHC of CDC47/MCM7, Akt and Phospho-Akt in response to 17β-estradiol (E2) in rat endometrium. Animals were ovariect-
omized for at least 10 days and then injected daily with E2 (or vehicle for control group) for 3 days. Rats were killed and their 
uteri collected, fixed and sectioned for IHC. IHC shown are from one representative experiment and were repeated five times 
using five different uterine sections from five different rats per day of estrous cycle. Arrow indicates strong redistribution of 
Phospho-Akt at the membrane level. LE = luminal epithelium, S = stroma.
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through the stages of estrous cycle studied indicating that
PTEN is a constitutively expressed protein. In the human
endometrium, PTEN has been shown to be regulated by
progesterone [37]. However, the rat uterus does not
undergo decidualization during the estrous cycle as com-
pared to the menstrual cycle in women. Thus, PTEN might
be an important protein involved in embryo implantation
processes when decidualization initiate rather than a role
during the regulation of estrous cycle in the rat
endometrium.
Recent studies demonstrated that the transcriptional
nuclear factor kappa-B (NF-κB) is a direct downstream tar-
get of phosphorylated Akt [38]. NF-κB is sequestered (p65
and p50 subunits) in the cytoplasm by the IκBs inhibitors
which are phosphorylation targets of Akt. Upon phospho-
rylation IκBs are released and degradated through ubiqui-
tination and NF-κB enter nucleus for gene expression
[39]. In the literature, we found that X-linked inhibitor of
apoptosis protein (XIAP) promoter is a target for NF-κB
[40,41]. Since we have shown previously in rat granulosa
cells and human ovarian surface epithelial cancer cells
that XIAP might be involved in the regulation of Akt activ-
ity .[18,25], it is possible that Akt may act on this family
of inhibitor of apoptosis protein in order to block apop-
tosis processes. Whether XIAP or other inhibitor of apop-
tosis proteins are involved in this process remains to be
investigated.
In conclusion, these results document for the first time the
presence and regulation of Akt in the rat endometrium
during the estrous cycle and further demonstrate that this
survival factor is regulated by 17β-estradiol. Further anal-
ysis will be necessary to determine more specifically, the
intra-cellular and molecular signal transducers involved
in the process of apoptosis in the rat reproductive tract.
Whether TNF-α or other cytokines/growth factors such as
TGF-β, IGF-1 or EGF may be involved in the regulation of
programmed cell death through Akt and inhibitors of
apoptosis proteins in the rat uterus remain to be eluci-
dated. Currently, investigations are carried out to further
characterize the role and mechanism of Akt on cell sur-
vival/apoptosis using endometrial (epithelial and stromal
cells) cultured in vitro .
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